Exploration of the mechanism of aloin ameliorates of combined allergic rhinitis and asthma syndrome based on network pharmacology and experimental validation.

Feng, Yan; Qiao, Han; Liu, Hongyun; Wang, Jvfei; Tang, Huaping

Feng, Yan; Qiao, Han; Liu, Hongyun; Wang, Jvfei; Tang, Huaping.

Afiliação

Feng Y; Department of Respiratory Medicine, Qingdao University, Qingdao, China.
Qiao H; Department of Respiratory Medicine, Qingdao University, Qingdao, China.
Liu H; Department of Pathology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China.
Wang J; Department of Respiratory Medicine, Qingdao University, Qingdao, China.
Tang H; Department of Respiratory Medicine, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China.

Front Pharmacol ; 14: 1218030, 2023.

Article em En | MEDLINE | ID: mdl-37781715

Palavras-chave

MAPK signaling pathway; aloin; combined allergic rhinitis and asthma syndrome; molecular dynamics; network pharmacology

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google